We are live on ! Find out more
EVH icon

Evolent Health

250 hedge funds and large institutions have $4.12B invested in Evolent Health in 2024 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 89 increasing their positions, 79 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% more call options, than puts

Call options by funds: $15.5M | Put options by funds: $7.82M

78% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 23

40% more funds holding in top 10

Funds holding in top 10: 5 → 7 (+2)

13% more repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 79

7% more funds holding

Funds holding: 234 → 250 (+16)

7% less capital inflows, than outflows

Capital inflows: $321M | Capital outflows: $343M

1.01% less ownership

Funds ownership: 110.01% → 109% (-1%)

Holders
250
Holders Change
+16
Holders Change %
+6.84%
% of All Funds
3.59%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.1%
New
41
Increased
89
Reduced
79
Closed
23
Calls
$15.5​M
Puts
$7.82​M
Net Calls
+$7.69​M
Net Calls Change
+$15.1​M

EVH Hedge Fund Activity: Q1 2024 in Review

250 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q1 2024, worth a combined $4.12B — down 1.3% from $4.18B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new EVH positions and 23 closed out — a net gain of 18 holders — while 89 added to existing stakes and 79 trimmed.

The largest buyer was RA Capital Management, adding an estimated $102M. The largest seller was Fidelity Investments, cutting an estimated $73.3M.

  • 250 institutional investors held Evolent Health (EVH) as of Q1 2024, up from 234 in Q4 2023.
  • Funds reported $4.12B of Evolent Health stock for Q1 2024, down 1.3% quarter-over-quarter.
  • 41 funds opened new Evolent Health positions in Q1 2024 and 23 closed out, a net change of +18 holders.
  • The largest Evolent Health buyer in Q1 2024 was RA Capital Management, an estimated $102M added.
  • The largest Evolent Health seller in Q1 2024 was Fidelity Investments, an estimated $73.3M sold.

Based on aggregated 13F filings for Q1 2024.